Reduced dementia incidence following varicella zoster vaccination in Wales 2013--2020

INTRODUCTION: Chronic infection with herpes viruses is a potential contributing factor to the development of dementia. The introduction of nationwide shingles (varicella zoster) vaccination in Wales might therefore be associated with reduced incident dementia. METHODS: We analyzed the association of shingles vaccination with incident dementia in Wales between 2013 and 2020 using retrospectively collected national health data. RESULTS: Vaccinated individuals were at reduced risk of dementia (adjusted hazard ratio: 0.72; 95% CI: 0.69 to 0.75). The association was not modified by a reduction in shingles diagnosis and was stronger for vascular dementia than for Alzheimers disease. Vaccination was also associated with a reduction in several other diseases and all-cause mortality. DISCUSSION: Our study shows a clear association of shingles vaccination with reduced dementia, consistent with other observational cohort studies. The association may reflect selection bias with people choosing to be vaccinated having a higher healthy life expectancy.

[1]  E. Halperin,et al.  Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimer’s Disease and Parkinson’s Disease , 2021, Vaccines.

[2]  T. Wiemken,et al.  Lower Risk for Dementia Following Adult Tetanus, Diphtheria and Pertussis (Tdap) Vaccination. , 2021, The journals of gerontology. Series A, Biological sciences and medical sciences.

[3]  P. Nordström,et al.  Herpesvirus infections, antiviral treatment, and the risk of dementia—a registry‐based cohort study in Sweden , 2021, Alzheimer's & dementia.

[4]  Jae-Sung Lim,et al.  Herpes Zoster Does Not Increase the Risk of Neurodegenerative Dementia: A Case-Control Study , 2021, American journal of Alzheimer's disease and other dementias.

[5]  G. Waldemar,et al.  Antiherpetic medication and incident dementia: Observational cohort studies in four countries , 2020, medRxiv.

[6]  Naaheed Mukadam,et al.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission , 2020, The Lancet.

[7]  Joon Seo Lim,et al.  Association of herpes zoster with dementia and effect of antiviral therapy on dementia: a population-based cohort study , 2020, European Archives of Psychiatry and Clinical Neuroscience.

[8]  D. Lynn,et al.  The non-specific and sex-differential effects of vaccines , 2020, Nature Reviews Immunology.

[9]  K. Blom,et al.  Effectiveness of the herpes zoster vaccine Zostavax® in Stockholm County, Sweden. , 2019, Vaccine.

[10]  C. Sudlow,et al.  Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data , 2019, European Journal of Epidemiology.

[11]  R. Lathe,et al.  The antimicrobial protection hypothesis of Alzheimer's disease , 2018, Alzheimer's & Dementia.

[12]  L. Joosten,et al.  Non-specific effects of vaccines: Current evidence and potential implications. , 2018, Seminars in immunology.

[13]  R. Lathe,et al.  Herpes Viruses and Senile Dementia: First Population Evidence for a Causal Link. , 2018, Journal of Alzheimer's disease : JAD.

[14]  H. Bedford,et al.  Analysis of factors associated with changing general practice in the first 14 years of life in Wales using linked cohort and primary care records: implications for using primary care databanks for life course research , 2018, International Journal of Population Data Science.

[15]  Hugo Lövheim,et al.  Microbes and Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.

[16]  John Young,et al.  Development and validation of an electronic frailty index using routine primary care electronic health record data , 2016, Age and ageing.

[17]  Shing-Hwa Liu,et al.  Influenza Vaccination Reduces Dementia Risk in Chronic Kidney Disease Patients , 2016, Medicine.

[18]  R. Lathe,et al.  Atherosclerosis and Alzheimer - diseases with a common cause? Inflammation, oxysterols, vasculature , 2014, BMC Geriatrics.

[19]  Koen Milisen,et al.  Prevalence of frailty and its ability to predict in hospital delirium, falls, and 6-month mortality in hospitalized older patients , 2014, BMC Geriatrics.

[20]  C. Iadecola,et al.  The Pathobiology of Vascular Dementia , 2013, Neuron.

[21]  Joanne C. Demmler,et al.  Development and use of a privacy-protecting total population record linkage system to support observational, interventional, and policy relevant research , 2012, The Lancet.

[22]  Ivan S F Chan,et al.  Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  R. Hubbard,et al.  Identifying the clinical characteristics of older people living in care homes using a novel approach in a primary care database. , 2010, Age and ageing.

[24]  P. Rose,et al.  Validity of diagnostic coding within the General Practice Research Database: a systematic review. , 2010, The British journal of general practice : the journal of the Royal College of General Practitioners.

[25]  David P. Martin,et al.  Herpes zoster (shingles) and postherpetic neuralgia. , 2009, Mayo Clinic proceedings.

[26]  Cecile Viboud,et al.  Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. , 2007, The Lancet. Infectious diseases.

[27]  J. Lindsay,et al.  Past exposure to vaccines and subsequent risk of Alzheimer's disease. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[28]  B. Dubois,et al.  Results from a Phase II Study to Assess the Clinical and Immunological Activity of AFFITOPE® AD02 in Patients with Early Alzheimer's Disease. , 2015, The journal of prevention of Alzheimer's disease.